CRISPRMED24 Sponsors and Supporters
CRISPRMED24 Sponsors and Supporters
CRISPRMED24
  • Meet the European CRISPR Medicine/Genomic Medicine community in Copenhagen, Denmark 2024.
  • Focus: Tools, Delivery, Safety/Off-target, Diseases, Pre-clinical/clinical, Standards and Regulations | Functional Genomics, Target Identification, Target Validation.
  • Segments: University, Hospital, Biotech, Pharma, CRO.
  • +500 delegates, +25 speakers confirmed (additional +25 speakers selected from abstracts), Poster sessions, Workshops, Network meetings...
  • Early bird registration until 1st December 2023.
  • Abstract submission deadline 5th January 2024.
  • Venue Site: Øksnehallen, Copenhagen, Denmark.
  • Organiser: CRISPR Medicine News, CMN.
  • Go to the official website here.
Keynote Speaker
Keynote Speaker

Luigi Naldini, M.D., Ph.D., is Professor of Cell and Tissue Biology and of Gene and Cell Therapy at the San Raffaele University School of Medicine and Scientific Director of the San Raffaele Telethon Institute for Gene Therapy (Milan, Italy). He received his medical degree from the University of Turin (Italy) and his PhD from the University “La Sapienza” of Rome (Italy).

For the past 25 years he has pioneered the development and application of lentiviral vectors for gene therapy, which have become one of the most widely used tools in biomedical research and, upon recently entering clinical testing, are providing a long-sought hope of cures for several currently untreatable and otherwise deadly human diseases. Throughout this time, he has continued to investigate new strategies to overcome the major hurdles to safe and effective gene transfer, bringing about innovative solutions that are not only being translated into new therapeutic strategies for genetic disease and cancer, but have also yielded novel insights into haematopoietic stem cell function, induction of immunological tolerance, and tumour angiogenesis.

Professor Naldini's work has also contributed to advancing the use of artificial nucleases for targeted genome editing in cell- and gene therapy. To date, he has published over 290 scientific papers, and his SCOPUS Author h-index is 105. He is also co-founder of three innovative biotech start-up companies: Genenta (recently listed on Nasdaq), Epsilen Bio (now acquired by Chroma Medicine) and Genespire.

Scientific Committee
  • Karen O´Hanlon Cohrt, Chief Editor CRISPR Medicine News, CMN
  • Toni Cathomen, Prof., Director of the Institute for Transfusion Medicine and Gene Therapy, University of Freiburg, Germany
  • Marcello Maresca, Senior Director, Genome Engineering Team, AstraZeneca, Sweden
  • Alessia Cavazza, Ass. Prof., Group Leader, University College London's Great Ormond Street Institute of Child Health, England
  • Anna Cereseto, Prof., Vice-Director, Centre for Integrative Biology (CIBIO), University of Trento, Italy
CRISPRMED24 Speakers (early confirmation)
  • Dr. André Cohnen, Head of Genomic Medicine, Senior Bayer Science Fellow, Bayer, Germany
  • Karina Thorn, Corporate Vice President, PhD, RNA and Gene Therapies, Global Research Technologies, Novo Nordisk, Denmark
  • Rasmus O. Bak, Ass. Prof. and Group leader, Aarhus University, Denmark
  • Xavier Duportet, CEO and Co-founder, Eligo Bioscience, France
  • Toni Cathomen, Prof. and Director of the Institute for Transfusion Medicine and Gene Therapy, University of Freiburg, Germany
  • Marcello Maresca, Senior Director, Genome Engineering Team, AstraZeneca, Sweden
  • Dr. Christian Groendahl, CEO and Co-founder, SNIPR Biome, Denmark
  • Dr. Pia Johansson, Manager Cell and Gene Therapy Core, Lund University, Sweden
  • Avencia Sanchez-Mejias Garcia, CEO and Co-founder, INTEGRA Therapeutics, Spain
  • Andre Choulika, CEO, Cellectis, France
  • Jan Gorodkin, Prof. and Group leader, University of Copenhagen, Denmark
  • Dr. Ayal Hendal, Principal Investigator and Group leader, Bar-Ilan University, Israel
  • Dr. Andrew Bellinger, CSO, Verve Therapeutics, US
  • Alessia Cavazza, Ass. Prof., Group Leader, Infection, Immunity & Inflammation Department at University College London's Great Ormond Street Institute of Child Health, England
  • Yonglun Luo, Professor, Gene and Stem Cell Technology, Aarhus University, Denmark
  • Kevin Holden, PhD, Head of Science, Synthego, US
  • Dr. Manuel Kaulich, Prof., Goethe University Frankfurt, Germany
  • Anna Cereseto, Prof., Vice-Director, Centre for Integrative Biology (CIBIO), University of Trento, Italy
  • Bernhard Schmierer, Head of Unit, CRISPR Functional Genomics, SciLifeLab and Karolinska Institutet, Stockholm, Sweden
  • Dr. Ben P. Kleinstiver, PhD, Assistant Professor at Center for Genomic Medicine, Massachusetts General Hospital and Harvard Medical School, US
  • Samantha Maragh, PhD, Leader, Genome Editing Program, National Institute of Standards & Technology (NIST), US

Check the full list of confirmed speakers here

 

Attendees (confirmed)

Attendees (confirmed)
Stay Updated

Official website will be live September 2023.

Stay updated about the program, abstract submissions and early registration options - sign up to the CRISPRMED24 Newsletter.

Sorry - something went wrong, your inquiry has not been sent!!
Thanks for your interest for the CRISPR Medicine Conference 2024. We will soon share more details.

Terms and Conditions
The CRISPRMED24 Newsletter is published by CRISPR Medicine Media Aps organiser of the CRISPR Medicine Conference. The CRISPR Medicine Media team is committed to protecting and respecting my privacy. CRISPR Medicine Media will guard my information responsibly and never share my email address. When I subscribe to the CRISPRMED24 Newsletter via this online form or email, I consent to CRISPR Medicine Media registering my email address to deliver email content.I may revoke my consent at any given time. CRISPR Medicine Media will delete my contact details when I terminate my subscription.

Interested to learn more about the Sponsorship or Exhibitor Packages?

Few sponsorship packages and exhibitor spaces will be available. Contact us today to learn more.

Sorry - something went wrong, your inquiry has not been sent!!
Thanks for your interest for the CRISPR Medicine Conference 2024. We will soon share more details.
close
Search CRISPR Medicine